Cytiva Executive and Leadership Team

Brittany Hissey, the Chief Financial Officer, Hardware Solutions at Cytiva, manages the fiscal health of the hardware manufacturing division. Hissey directs capital allocation strategies to support the production of advanced medical technologies. By overseeing financial planning and analysis, the Chief Financial Officer, Hardware Solutions ensures that resource distribution aligns with the broader corporate goal of accelerating therapeutic development. Hissey monitors global supply chain costs to maintain competitive margins across North American and European markets. This leadership role involves rigorous oversight of hardware investment portfolios to drive long-term profitability. Through precise budgetary control, Brittany Hissey optimizes the financial performance of the hardware sector. The Chief Financial Officer, Hardware Solutions maintains transparency with the board regarding fiscal risks and growth opportunities. By implementing robust financial frameworks, Hissey secures the necessary capital to fuel innovation in medical manufacturing, ultimately strengthening the market position of the organization.

Allen Li, the President at Cytiva, oversees the entire scope of global operations and corporate strategy. Li directs the execution of the company mission to provide essential medical technologies that advance therapeutic development. By coordinating the efforts of the executive leadership team, the President ensures that all departments remain aligned with the long-term growth objectives of the organization. Li manages the expansion of market reach across diverse international territories, ensuring that the company maintains a strong presence in key medical hubs. This leadership role involves high-level engagement with the board to define the strategic direction of the business. Allen Li fosters an environment of operational excellence, driving efficiency in manufacturing and service delivery. The President monitors global market dynamics to identify new opportunities for expansion and innovation. Through decisive leadership, Li ensures that the organization continues to deliver high-value solutions that meet the complex needs of the global healthcare industry.

Steve Eichorn, the Vice President, Information Technology & Chief Information Officer at Cytiva, architects the digital infrastructure supporting global medical technology operations. Eichorn drives the implementation of secure data systems that facilitate rapid therapeutic research and development. Overseeing the enterprise-wide digital transformation, the Vice President, Information Technology & Chief Information Officer ensures that internal networks remain resilient against cyber threats while supporting high-speed data processing requirements. Eichorn manages the integration of cloud-based platforms to enhance collaboration across international research facilities. This leadership role requires constant alignment with the Chief Technology Officer to ensure that software solutions meet the rigorous demands of the life sciences industry. Steve Eichorn optimizes IT spending to maximize operational efficiency across all global regions. By modernizing legacy systems, the Vice President, Information Technology & Chief Information Officer enables seamless data flow, which directly accelerates the speed at which new medical solutions reach the global market.

Aaron Dulgar-Tulloch, the Chief Technology Officer, Genomic Medicine at Cytiva, leads the research and development initiatives focused on advanced genomic therapies. Dulgar-Tulloch directs the engineering of specialized tools that enable scientists to accelerate the creation of life-saving treatments. Overseeing the technical roadmap for genomic medicine, the Chief Technology Officer, Genomic Medicine ensures that the company remains at the forefront of biotechnology innovation. Dulgar-Tulloch collaborates with external research partners to integrate cutting-edge methodologies into the existing product portfolio. This leadership role involves managing complex technical projects that span across global research hubs. By fostering a culture of scientific inquiry, Aaron Dulgar-Tulloch drives the development of proprietary technologies that solve critical challenges in therapeutic manufacturing. The Chief Technology Officer, Genomic Medicine monitors emerging trends in the life sciences sector to anticipate future market needs. Through strategic technical oversight, Dulgar-Tulloch ensures that the organization maintains a competitive edge in the rapidly evolving field of genomic medicine.